Millennium Management LLC Buys 77,495 Shares of Option Care Health, Inc. $OPCH

Key Points

• Millennium Management LLC increased its holdings in Option Care Health by 5.9%, owning approximately 0.84% of the company, valued at $48.3 million at the end of the first quarter.
• Directors Harry M. Jansen Kraemer, Jr. and Timothy P. Sullivan significantly increased their stock positions, with Kraemer acquiring 36,000 shares and Sullivan purchasing 20,000 shares.
• Option Care Health reported a 15.4% year-over-year revenue increase for the quarter, achieving $1.42 billion, and provided FY 2025 earnings guidance of $1.650-1.720 EPS.

Millennium Management LLC increased its position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 5.9% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,382,110 shares of the company's stock after acquiring an additional 77,495 shares during the quarter. Millennium Management LLC owned about 0.84% of Option Care Health worth $48,305,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in OPCH. Northwestern Mutual Wealth Management Co. raised its holdings in Option Care Health by 1,492.9% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company's stock worth $31,000 after purchasing an additional 836 shares during the last quarter. Brooklyn Investment Group boosted its stake in shares of Option Care Health by 186.6% in the 1st quarter. Brooklyn Investment Group now owns 1,198 shares of the company's stock valued at $42,000 after purchasing an additional 780 shares during the last quarter. Public Employees Retirement System of Ohio grew its position in shares of Option Care Health by 21.6% during the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock worth $43,000 after buying an additional 332 shares during the period. Bessemer Group Inc. grew its position in shares of Option Care Health by 62.3% during the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock worth $54,000 after buying an additional 599 shares during the period. Finally, Wealthquest Corp bought a new stake in shares of Option Care Health during the first quarter worth approximately $66,000. Institutional investors own 98.05% of the company's stock.

Insider Buying and Selling

In other Option Care Health news, Director Timothy P. Sullivan purchased 20,000 shares of the stock in a transaction on Thursday, August 21st. The stock was bought at an average cost of $27.51 per share, for a total transaction of $550,200.00. Following the completion of the acquisition, the director directly owned 49,229 shares of the company's stock, valued at $1,354,289.79. The trade was a 68.43% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Norman L. Wright acquired 3,411 shares of the business's stock in a transaction dated Tuesday, September 9th. The shares were acquired at an average price of $29.31 per share, for a total transaction of $99,976.41. Following the acquisition, the director directly owned 15,501 shares in the company, valued at $454,334.31. This represents a 28.21% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last quarter, insiders have acquired 59,411 shares of company stock valued at $1,627,576. 0.64% of the stock is owned by company insiders.

Option Care Health Trading Down 3.0%

NASDAQ OPCH traded down $0.89 during trading on Friday, reaching $28.48. 1,626,043 shares of the stock traded hands, compared to its average volume of 1,842,623. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.81. The firm has a market cap of $4.62 billion, a price-to-earnings ratio of 22.78, a price-to-earnings-growth ratio of 1.79 and a beta of 0.82. The stock's 50-day moving average price is $29.09 and its 200 day moving average price is $31.44.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.01. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. The company had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.35 billion. During the same period last year, the business posted $0.30 earnings per share. The business's revenue for the quarter was up 15.4% compared to the same quarter last year. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. Analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current year.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on OPCH. Citigroup reaffirmed an "outperform" rating on shares of Option Care Health in a research note on Thursday, July 31st. JMP Securities increased their price target on Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a research note on Thursday, July 31st. Finally, Barrington Research restated an "outperform" rating and issued a $38.00 price target on shares of Option Care Health in a research report on Thursday, July 10th. Eight investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, Option Care Health presently has an average rating of "Moderate Buy" and a consensus price target of $35.75.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.